ALS Solutions provides you with online access to your sample and analytical information from anywhere.
LoginRetrieve results and track sample progress in real time with access to featured digital products such as CoreViewer™ and ALS QCPro™.
LoginThis convenient application lets customers closely track oil analysis reports in process in real time.
LoginRequest a quote for our quality-assured analysis and testing services, and we will get back to you within the next business day.
Have questions or comments about our services? Please send us a message and we will get in touch with you soon.
CONTACT USThere are many different patch types studies used for assessing the safety of topical products. ALS is a leading source of shared human repeat insult patch tests (HRIPT), as well as primary irritation, and cumulative irritation tests. Whether you are looking for simple safety test on 50 subjects, or an FDA filing requiring 200, ALS is ready to assist you.
ALS has multiple sites for conducting our shared HRIPT panels located in the USA and Latin America that allow us to build a robust recruitment pipeline. ALS has the most organized reporting system, allowing us to issue reports within five business days of the completion of our panels, where competitors take several weeks.
ALS is the number one provider of HRIPT for personal care, OTC drug, and topical medical devices in the USA. Repeat Insult Patch Testing (HRIPT) is the personal care industry’s standard safety test for cosmetic, OTC drug, and topical medical devices. HRIPT is a patch test conducted over six weeks where human subjects have patches containing test products applied to the back to identify irritation or allergy response. Our shared HRIPT take place every week and results are reported within five business days of completion of the study. Dermatologist tested claims are included on all panels. Sensitive skin subjects are also available on panels that start monthly.
Cumulative irritation (CI) is an exaggerated patch test to help identify irritation potential of different formulations. ALS offers standard 5, 7, 14, and 21-day cumulative irritation panels performed in the USA or Latin America.
ALS offers Primary Irritation concurrent with our normal HRIPT panel schedule. Primary irritation is a single 48-hour exposure patch test on 50, 100, or 200 human subjects.
No, if you can provide the ingredient list and usage instructions ALS experts can determine what patch is correct for your sample.
There is no standard for the claim “hypoallergenic”. Clients are encouraged to refer to the FDA website page.
Para sua conveniência e segurança, estabelecemos uma parceria com a PayJunction para concluir a transação do seu cartão de crédito. As informações do seu cartão de crédito serão utilizadas apenas para processar um pagamento único.
Se não tiver um número de fatura, não continue e ligue para:
Valores a receber +1 281-575-2290
Para sua conveniência e segurança, estabelecemos uma parceria com a Westpac, para concluir a transação do seu cartão de crédito. As informações do seu cartão de crédito serão utilizadas apenas para processar um pagamento único. A ALS irá gerir e respeitar as suas informações pessoais de acordo com a sua Política de Privacidade.
Pague com Visa, Mastercard ou American Express. A moeda é processada em dólares australianos (AUD). Será aplicada uma taxa adicional de cartão de crédito de 0,8 % (Visa/MC) ou 1,5 % (AMEX) a todas as transações (incluindo GST aplicável).
Esta facilidade de pagamento está disponível para todos os clientes (com base na Austrália) com um número de fatura válido. Se não tiver um número de fatura, não continue e ligue para:
Valores a receber +61 7 3212 5498
Selecione a entidade legal ALS a partir das opções abaixo. O nome da entidade ALS pode ser encontrado na sua fatura.